{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 477213877
| IUPAC_name = (8''R'',9''S'',13''S'',14''S'',17''S'')-2-Methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
| image = 2-Methoxyestradiol.svg
| width = 250px

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S8 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 362-07-2
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 66414
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 59788
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 6I2QW73SR5
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 28955
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 299613
| synonyms = 2-ME2; 2-MeO-E2; 2-MeOE2; 2-Hydroxyestradiol 2-methyl ether; 2-Methoxyestra-1,3,5(10)-triene-3,17β-diol; Panzem

<!--Chemical data-->
| C=19 | H=26 | O=3 
| SMILES = Oc1cc3c(cc1OC)[C@H]2CC[C@@]4([C@@H](O)CC[C@H]4[C@@H]2CC3)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = CQOQDQWUFQDJMK-SSTWWWIQSA-N
| melting_point = 186
| melting_high = 189
| melting_notes = <ref>{{cite journal|journal=Steroids|volume=75|issue=1|language=en|date=2010-01|pages=53–56|doi=10.1016/j.steroids.2009.09.013|url=https://linkinghub.elsevier.com/retrieve/pii/S0039128X09002190|title=An efficient, practical synthesis of 2-methoxyestradiol|accessdate=2021-01-26|author=Minhang Xin, Qidong You, Hua Xiang}}</ref>
}}
'''2-甲氧基雌二醇'''（{{lang-en|2-Methoxyestradiol}}，缩写'''2-ME2'''或'''2-MeO-E2'''）是一种[[雌二醇|雌二醇]]（E2）和[[2-羟基雌二醇|2-羟基雌二醇]]（2-OHE2）的[[天然产物|天然]][[代謝產物|代謝產物]]，可看作是[[儿茶酚雌激素|儿茶酚雌激素]][[2-羟基雌二醇|2-羟基雌二醇]]的2-O-[[甲基|甲基]][[醚|醚]]。2-甲氧基雌二醇是一种[[血管新生|血管新生]]抑制剂<ref>{{cite journal | vauthors = Pribluda VS, Gubish ER, Lavallee TM, Treston A, Swartz GM, Green SJ | title = 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate | journal = Cancer Metastasis Reviews | volume = 19 | issue = 1–2 | pages = 173–9 | date = 2000 | pmid = 11191057 | doi=10.1023/a:1026543018478| s2cid = 20055299 }}</ref>。
== 参考资料 ==
{{reflist|25em}}
== 外部链接 ==
{{甾体激素}}
{{DEFAULTSORT:甲氧基雌二醇, 2-}}

[[Category:血管生成抑制剂|Category:血管生成抑制剂]]
[[Category:抗肿瘤药|Category:抗肿瘤药]]
[[Category:人体代谢物|Category:人体代谢物]]